Gurzhenko Y. Study of the Efficiency of Using Type 5 Phosphodiesterase Inhibitors in the Therapy of Ereсtile Dysfunction in Patients with Metabolic Syndrome. HM [Internet]. 2021Sep.30 [cited 2024Oct.18];(3):58-69. Available from: https://health-man.com.ua/2412-5547/article/view/246211